Literature DB >> 14612416

Human immunodeficiency virus type 1 hnRNP A/B-dependent exonic splicing silencer ESSV antagonizes binding of U2AF65 to viral polypyrimidine tracts.

Jeffrey K Domsic1, Yibin Wang, Akila Mayeda, Adrian R Krainer, C Martin Stoltzfus.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) exonic splicing silencers (ESSs) inhibit production of certain spliced viral RNAs by repressing alternative splicing of the viral precursor RNA. Several HIV-1 ESSs interfere with spliceosome assembly by binding cellular hnRNP A/B proteins. Here, we have further characterized the mechanism of splicing repression using a representative HIV-1 hnRNP A/B-dependent ESS, ESSV, which regulates splicing at the vpr 3' splice site. We show that hnRNP A/B proteins bound to ESSV are necessary to inhibit E complex assembly by competing with the binding of U2AF65 to the polypyrimidine tracts of repressed 3' splice sites. We further show evidence suggesting that U1 snRNP binds the 5' splice site despite an almost complete block of splicing by ESSV. Possible splicing-independent functions of U1 snRNP-5' splice site interactions during virus replication are discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14612416      PMCID: PMC262674          DOI: 10.1128/MCB.23.23.8762-8772.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  52 in total

1.  The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element.

Authors:  T O Tange; C K Damgaard; S Guth; J Valcárcel; J Kjems
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

Review 2.  Retroviruses as model systems for the study of nuclear RNA export pathways.

Authors:  B R Cullen
Journal:  Virology       Date:  1998-09-30       Impact factor: 3.616

3.  Splicing efficiency of human immunodeficiency virus type 1 tat RNA is determined by both a suboptimal 3' splice site and a 10 nucleotide exon splicing silencer element located within tat exon 2.

Authors:  Z Si; B A Amendt; C M Stoltzfus
Journal:  Nucleic Acids Res       Date:  1997-02-15       Impact factor: 16.971

4.  The retroviruses human immunodeficiency virus type 1 and Moloney murine leukemia virus adopt radically different strategies to regulate promoter-proximal polyadenylation.

Authors:  A Furger; J Monks; N J Proudfoot
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing.

Authors:  M Caputi; A Mayeda; A R Krainer; A M Zahler
Journal:  EMBO J       Date:  1999-07-15       Impact factor: 11.598

6.  A cooperative interaction between U2AF65 and mBBP/SF1 facilitates branchpoint region recognition.

Authors:  J A Berglund; N Abovich; M Rosbash
Journal:  Genes Dev       Date:  1998-03-15       Impact factor: 11.361

7.  Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins.

Authors:  J Zhu; A Mayeda; A R Krainer
Journal:  Mol Cell       Date:  2001-12       Impact factor: 17.970

8.  Targeting of U2AF65 to sites of active splicing in the nucleus.

Authors:  M Gama-Carvalho; R D Krauss; L Chiang; J Valcárcel; M R Green; M Carmo-Fonseca
Journal:  J Cell Biol       Date:  1997-06-02       Impact factor: 10.539

9.  The exon splicing silencer in human immunodeficiency virus type 1 Tat exon 3 is bipartite and acts early in spliceosome assembly.

Authors:  Z H Si; D Rauch; C M Stoltzfus
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

10.  Dual function for U2AF(35) in AG-dependent pre-mRNA splicing.

Authors:  S Guth; T Ø Tange; E Kellenberger; J Valcárcel
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

View more
  29 in total

1.  New way of regulating alternative splicing in retroviruses: the promoter makes a difference.

Authors:  Jens Bohne; Axel Schambach; Daniela Zychlinski
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

2.  Role of cellular RNA processing factors in human immunodeficiency virus type 1 mRNA metabolism, replication, and infectivity.

Authors:  Joseph A Jablonski; Massimo Caputi
Journal:  J Virol       Date:  2008-11-12       Impact factor: 5.103

Review 3.  Idiosyncrasies of hnRNP A1-RNA recognition: Can binding mode influence function.

Authors:  Jeffrey D Levengood; Blanton S Tolbert
Journal:  Semin Cell Dev Biol       Date:  2018-04-09       Impact factor: 7.727

Review 4.  Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development.

Authors:  Qianya Wan; Dan Song; Huangcan Li; Ming-Liang He
Journal:  Signal Transduct Target Ther       Date:  2020-07-13

5.  Analysis of Competing HIV-1 Splice Donor Sites Uncovers a Tight Cluster of Splicing Regulatory Elements within Exon 2/2b.

Authors:  Anna-Lena Brillen; Lara Walotka; Frank Hillebrand; Lisa Müller; Marek Widera; Stephan Theiss; Heiner Schaal
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

6.  Tra2-mediated recognition of HIV-1 5' splice site D3 as a key factor in the processing of vpr mRNA.

Authors:  Steffen Erkelenz; Gereon Poschmann; Stephan Theiss; Anja Stefanski; Frank Hillebrand; Marianne Otte; Kai Stühler; Heiner Schaal
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

7.  Genomic HEXploring allows landscaping of novel potential splicing regulatory elements.

Authors:  Steffen Erkelenz; Stephan Theiss; Marianne Otte; Marek Widera; Jan Otto Peter; Heiner Schaal
Journal:  Nucleic Acids Res       Date:  2014-08-21       Impact factor: 16.971

8.  Serine- and arginine-rich proteins 55 and 75 (SRp55 and SRp75) induce production of HIV-1 vpr mRNA by inhibiting the 5'-splice site of exon 3.

Authors:  Anna Tranell; Eva Maria Fenyö; Stefan Schwartz
Journal:  J Biol Chem       Date:  2010-08-04       Impact factor: 5.157

9.  An intronic G run within HIV-1 intron 2 is critical for splicing regulation of vif mRNA.

Authors:  Marek Widera; Steffen Erkelenz; Frank Hillebrand; Aikaterini Krikoni; Darius Widera; Wolfgang Kaisers; René Deenen; Michael Gombert; Rafael Dellen; Tanya Pfeiffer; Barbara Kaltschmidt; Carsten Münk; Valerie Bosch; Karl Köhrer; Heiner Schaal
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

10.  RNA structure modulates splicing efficiency at the human immunodeficiency virus type 1 major splice donor.

Authors:  Truus E M Abbink; Ben Berkhout
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.